All In Biotech

Drug Trial Radar · NCT03126916

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

Last checked: Nov 19, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 750 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

750

Planned (sponsor's estimate)

Start

May 14, 2018

Primary completion

Sep 30, 2030

Study completion Sep 30, 2030

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Apr 25, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 365 days, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Lorlatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving iobenguane I-131 or lorlatinib and standard therapy may work better compared to lorlatinib and standard therapy alone in treating younger patients with neuroblastoma or ganglioneuroblastoma.

Conditions

  • Ganglioneuroblastoma
  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma

Interventions

  • Autologous Hematopoietic Stem Cell TransplantationProcedure

    Undergo autologous HSCT

  • Biospecimen CollectionProcedure

    Undergo blood sample collection

  • Bone Marrow Aspiration and BiopsyProcedure

    Undergo bone marrow aspiration and biopsy

  • BusulfanDrug

    Given IV

  • CarboplatinDrug

    Given IV

  • CisplatinDrug

    Given IV

  • Computed TomographyProcedure

    Undergo CT scan

  • CyclophosphamideDrug

    Given IV

  • Dexrazoxane HydrochlorideDrug

    Given IV

  • DinutuximabBiological

    Given IV

  • Doxorubicin HydrochlorideDrug

    Given IV

  • Echocardiography TestProcedure

    Undergo echocardiography

  • Etoposide PhosphateDrug

    Given IV

  • External Beam Radiation TherapyRadiation

    Undergo EBRT

  • Iobenguane I-123Radiation

    Given 123 I-MIBG

  • Iobenguane I-131Radiation

    Given IV

  • IsotretinoinDrug

    Given PO

  • LorlatinibDrug

    Given PO

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • Melphalan HydrochlorideDrug

    Given IV

  • Multigated Acquisition ScanProcedure

    Undergo MUGA scan

  • Positron Emission TomographyProcedure

    Undergo PET scan

  • SargramostimBiological

    Given SC

  • Therapeutic Conventional SurgeryProcedure

    Undergo standard of care surgery

  • ThiotepaDrug

    Given IV

  • Topotecan HydrochlorideDrug

    Given IV

  • Vincristine SulfateDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event free survival (EFS) (Arm A, B, D, and E)Time frame: 3 years

Locations

164 sites in 3 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Alabama

    Birmingham, Alabama · Recruiting

  • Phoenix Childrens Hospital

    Phoenix, Arizona · Recruiting

  • Arkansas Children's Hospital

    Little Rock, Arkansas · Recruiting

  • Kaiser Permanente Downey Medical Center

    Downey, California · Recruiting

  • Loma Linda University Medical Center

    Loma Linda, California · Recruiting

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

  • Mattel Children's Hospital UCLA

    Los Angeles, California · Recruiting

  • Valley Children's Hospital

    Madera, California · Recruiting

  • Kaiser Permanente-Oakland

    Oakland, California · Recruiting

  • Children's Hospital of Orange County

    Orange, California · Recruiting

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California · Recruiting

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • Rady Children's Hospital - San Diego

    San Diego, California · Recruiting

  • Naval Medical Center -San Diego

    San Diego, California · Recruiting

  • UCSF Medical Center-Mission Bay

    San Francisco, California · Recruiting

  • Children's Hospital Colorado

    Aurora, Colorado · Recruiting

  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

    Denver, Colorado · Recruiting

  • Connecticut Children's Medical Center

    Hartford, Connecticut · Recruiting

  • Yale University

    New Haven, Connecticut · Recruiting

  • Alfred I duPont Hospital for Children

    Wilmington, Delaware · Recruiting

  • Children's National Medical Center

    Washington D.C., District of Columbia · Recruiting

  • Golisano Children's Hospital of Southwest Florida

    Fort Myers, Florida · Recruiting

  • UF Health Cancer Institute - Gainesville

    Gainesville, Florida · Recruiting

  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital

    Hollywood, Florida · Recruiting

  • Nemours Children's Clinic-Jacksonville

    Jacksonville, Florida · Recruiting

  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida · Recruiting

  • Nicklaus Children's Hospital

    Miami, Florida · Recruiting

  • AdventHealth Orlando

    Orlando, Florida · Recruiting

  • Nemours Children's Hospital

    Orlando, Florida · Recruiting

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida · Recruiting

  • Saint Mary's Medical Center

    West Palm Beach, Florida · Recruiting

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital

    Atlanta, Georgia · Recruiting

  • Memorial Health University Medical Center

    Savannah, Georgia · Recruiting

  • Kapiolani Medical Center for Women and Children

    Honolulu, Hawaii · Suspended

  • Saint Luke's Cancer Institute - Boise

    Boise, Idaho · Recruiting

  • Lurie Children's Hospital-Chicago

    Chicago, Illinois · Recruiting

  • University of Illinois

    Chicago, Illinois · Recruiting

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois · Recruiting

  • Advocate Children's Hospital-Oak Lawn

    Oak Lawn, Illinois · Recruiting

  • Advocate Children's Hospital-Park Ridge

    Park Ridge, Illinois · Recruiting

Showing 40 of 164 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.